Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMQG7ZM)

Drug Name

Belagenpumatucel-L Drug Info

Synonyms

Lucanix (TN)

Indication

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting TGF beta-2 messenger RNA (TGFB2 mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
OT-101	DMCTRLN	Melanoma	2C30	Phase 2/3	[3]
Ranagengliotucel-T	DMNTURD	Brain cancer	2A00	Discontinued in Phase 3	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
TGF beta-2 messenger RNA (TGFB2 mRNA)	TTI0KH6	TGFB2_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00676507) Phase III Lucanix Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy. U.S. National Institutes of Health.
2	National Cancer Institute Drug Dictionary (drug id 590662).
3	Clinical pipeline report, company report or official report of Oncotelic.
4	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017210)